As of 2025-07-01, the Intrinsic Value of Cerevel Therapeutics Holdings Inc (CERE) is -12.64 USD. This CERE valuation is based on the model Peter Lynch Fair Value. With the current market price of 44.96 USD, the upside of Cerevel Therapeutics Holdings Inc is -128.11%.
Based on its market price of 44.96 USD and our intrinsic valuation, Cerevel Therapeutics Holdings Inc (CERE) is overvalued by 128.11%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.64 - -12.64 | -12.64 | -128.11% |
| P/E | (18.70) - (31.85) | (24.52) | -154.5% |
| DDM - Stable | (25.03) - (80.77) | (52.90) | -217.7% |
| DDM - Multi | (1.44) - (3.58) | (2.05) | -104.6% |
| Market Cap (mil) | 8,191.26 |
| Beta | 1.22 |
| Outstanding shares (mil) | 182.19 |
| Enterprise Value (mil) | 8,208.75 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.94% |
| Cost of Debt | 5.00% |
| WACC | 8.79% |